This was accompanied by reductions in tumor-associated CD8+ T cells expressing CD73 (Supplementary Figure S8B) and IL-10 (Supplementary Figure S8B) in elderly, but not young, IL-2/CD40-treated mice, relative to PBS controls. This evidence concerns the gene CD40 and neoplasm.